The CD14 -159C/T polymorphisms and the risks of tuberculosis: A meta-analysis

Infection, Genetics and Evolution

Volumn 18, Issue , 2013, Pages 277-283

  Guo, Fang Fang ^a   Xie, Qing ^a   An, Ru Feng ^b   Zeng, Tao ^c   Zhou, Wen ^a  

^a SHANDONG UNIVERSITY   (China)

^b TAISHAN MEDICAL UNIVERSITY   (China)

^c SHANDONG UNIVERSITY   (China)

Author keywords

CD14; Gene polymorphism; Meta analysis; Tuberculosis

Indexed keywords

CD14 ANTIGEN;

ARTICLE; ASIAN; CAUCASIAN; CD14 GENE; ETHNIC DIFFERENCE; GENETIC ASSOCIATION; GENETIC MODEL; HUMAN; INFECTION RISK; LUNG TUBERCULOSIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TUBERCULOSIS;

CD14; GENE POLYMORPHISM; META-ANALYSIS; TUBERCULOSIS;

ADULT; ANTIGENS, CD14; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; TUBERCULOSIS;

EID: 84879806312     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2013.06.001     Document Type: Article

References (42)

1. Alavi-Naini R., Salimi S., Sharifi-Mood B., Davoodikia A.A., Moody B., Naghavi A. Association between the CD14 gene C-159T polymorphism and serum soluble CD14 with pulmonary tuberculosis. Int. J. Tuberc. Lung Dis. 2012, 16:1383-1387.
2. Ayaslioglu E., Kalpaklioglu F., Kavut A.B., Erturk A., Capan N., Birben E. The role of CD14 gene promoter polymorphism in tuberculosis susceptibility. J. Microbiol. Immunol. Infect. 2012, 10.1016/j.jmii.2012.1005.1008.
3. Azad A.K., Sadee W., Schlesinger L.S. Innate immune gene polymorphisms in tuberculosis. Infect. Immun. 2012, 80:3343-3359.
4. Baldini M., Lohman I.C., Halonen M., Erickson R.P., Holt P.G., Martinez F.D. A Polymorphism* in the 5' flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am. J. Respir. Cell Mol. Biol. 1999, 20:976-983.
5. Druszczynska M., Strapagiel D., Kwiatkowska S., Kowalewicz-Kulbat M., Rozalska B., Chmiela M., Rudnicka W. Tuberculosis bacilli still posing a threat. Polymorphism of genes regulating anti-mycobacterial properties of macrophages. Pol. J. Microbiol. 2006, 55:7-12.
6. Gu W., Dong H., Jiang D.P., Zhou J., Du D.Y., Gao J.M., Yao Y.Z., Zhang L.Y., Wen A.Q., Liu Q. Functional significance of CD14 promoter polymorphisms and their clinical relevance in a Chinese Han population. Crit. Care Med. 2008, 36:2274-2280.
7. Haerian B.S., Roslan H., Raymond A.A., Tan C.T., Lim K.S., Zulkifli S.Z., Mohamed E.H., Tan H.J., Mohamed Z. ABCB1 C3435T polymorphism and the risk of resistance to antiepileptic drugs in epilepsy: a systematic review and meta-analysis. Seizure 2010, 19:339-346.
8. Hailman E., Vasselon T., Kelley M., Busse L.A., Hu M., Lichenstein H.S., Detmers P.A., Wright S.D. Stimulation of macrophages and neutrophils by complexes of lipopolysaccharide and soluble CD14. J. Immunol. 1996, 156:4384-4390.
9. Heesen M., Blomeke B., Schluter B., Heussen N., Rossaint R., Kunz D. Lack of association between the -260 C->T promoter polymorphism of the endotoxin receptor CD14 gene and the CD14 density of unstimulated human monocytes and soluble CD14 plasma levels. Intensive Care Med. 2001, 27:1770-1775.
10. Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat. Med. 2002, 21:1539-1558.
11. Hoheisel G., Zheng L., Teschler H., Striz I., Costabel U. Increased soluble CD14 levels in BAL fluid in pulmonary tuberculosis. Chest 1995, 108:1614-1616.
12. Kang Y.A., Lee H.W., Kim Y.W., Han S.K., Shim Y.S., Yim J.J. Association between the -159C/T CD14 gene polymorphism and tuberculosis in a Korean population. FEMS Immunol. Med. Microbiol. 2009, 57:229-235.
13. Kleinnijenhuis J., Oosting M., Joosten L.A., Netea M.G., Van Crevel R. Innate immune recognition of Mycobacterium tuberculosis. Clin. Dev. Immunol. 2011, 2011:405310.
14. Lawn S.D., Labeta M., Arias M., Acheampong J., Griffin G. Elevated serum concentrations of soluble CD14 in HIV- and HIV+ patients with tuberculosis in Africa: prolonged elevation during anti-tuberculosis treatment. Clin. Exp. Immunol. 2001, 120:483-487.
15. Lawn S.D., Zumla A.I. Tuberculosis. Lancet 2011, 378:57-72.
16. LeVan T.D., Bloom J.W., Bailey T.J., Karp C.L., Halonen M., Martinez F.D., Vercelli D. A common single nucleotide polymorphism in the CD14 promoter decreases the affinity of Sp protein binding and enhances transcriptional activity. J. Immunol. 2001, 167:5838-5844.
17. Li X., Yang Y., Zhou F., Zhang Y., Lu H., Jin Q., Gao L. SLC11A1 (NRAMP1) polymorphisms and tuberculosis susceptibility: updated systematic review and meta-analysis. PLoS One 2011, 6:e15831.
18. Lin J.N., Lai C.H., Chen Y.H., Lee S.S., Tsai S.S., Huang C.K., Chung H.C., Liang S.H., Lin H.H. Risk factors for extra-pulmonary tuberculosis compared to pulmonary tuberculosis. Int. J. Tuberc. Lung Dis. 2009, 13:620-625.
19. Moller M., de Wit E., Hoal E.G. Past, present and future directions in human genetic susceptibility to tuberculosis. FEMS Immunol. Med. Microbiol. 2010, 58:3-26.
20. Musellim B., Erturan S., Sonmez Duman E., Ongen G. Comparison of extra-pulmonary and pulmonary tuberculosis cases: factors influencing the site of reactivation. Int. J. Tuberc. Lung Dis. 2005, 9:1220-1223.
21. Naing C., Mak J.W., Maung M., Wong S.F., Kassim A.I.B.M. Meta-analysis: the association between HIV infection and extrapulmonary tuberculosis. Lung 2013, 191:27-34.
22. Natarajan K., Kundu M., Sharma P., Basu J. Innate immune responses to M. tuberculosis infection. Tuberculosis (Edinb) 2011, 91:427-431.
23. Pacheco E., Fonseca C., Montes C., Zabaleta J., Garcia L.F., Arias M.A. CD14 gene promoter polymorphism in different clinical forms of tuberculosis. FEMS Immunol. Med. Microbiol. 2004, 40:207-213.
24. Peterson P.K., Gekker G., Hu S., Sheng W.S., Anderson W.R., Ulevitch R.J., Tobias P.S., Gustafson K.V., Molitor T.W., Chao C.C. CD14 receptor-mediated uptake of nonopsonized Mycobacterium tuberculosis by human microglia. Infect. Immun. 1995, 63:1598-1602.
25. Posthaus H., Bodmer T., Alves L., Oevermann A., Schiller I., Rhodes S.G., Zimmerli S. Accidental infection of veterinary personnel with Mycobacterium tuberculosis at necropsy: a case study. Vet. Microbiol. 2011, 149:374-380.
26. Pugin J., Heumann D., Tomasz A., Kravchenko V.V., Akamatsu Y., Nishijima M., Glauser M.P., Tobias P.S., Ulevitch R.J. CD14 is a pattern recognition receptor. Immunity 1994, 1:509-516.
27. Qu H.Q., Fisher-Hoch S.P., McCormick J.B. Knowledge gaining by human genetic studies on tuberculosis susceptibility. J. Hum. Genet. 2011, 56:177-182.
28. Rosas-Taraco A.G., Revol A., Salinas-Carmona M.C., Rendon A., Caballero-Olin G., Arce-Mendoza A.Y. CD14 C(-159)T polymorphism is a risk factor for development of pulmonary tuberculosis. J. Infect. Dis. 2007, 196:1698-1706.
29. Shabo I., Svanvik J. Expression of Macrophage Antigens by Tumor Cells. Cell Fusion in Health and Disease 2011, Elsevier, pp. 141-150.
30. Stefanova I., Horejsi V., Ansotegui I.J., Knapp W., Stockinger H. GPI-anchored cell-surface molecules complexed to protein tyrosine kinases. Science 1991, 254:1016-1019.
31. Tian T., Jin S., Dong J., Li G. Lack of association between Toll-like receptor 4 gene Asp299Gly and Thr399Ile polymorphisms and tuberculosis susceptibility: a meta-analysis. Infect. Genet. Evol. 2012, 14C:156-160.
32. Tobias A. Assessing the influence of a single study in the meta-analysis estimate. Stata Tech. Bull. 1999, 47:15-17.
33. Triantafilou M., Triantafilou K. Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster. Trends Immunol. 2002, 23:301-304.
34. Wang Q., Zhan P., Qiu L.X., Qian Q., Yu L.K. TNF-308 gene polymorphism and tuberculosis susceptibility: a meta-analysis involving 18 studies. Mol. Biol. Rep. 2012, 39:3393-3400.
35. Wieland C.W., van der Windt G.J., Wiersinga W.J., Florquin S., van der Poll T. CD14 contributes to pulmonary inflammation and mortality during murine tuberculosis. Immunology 2008, 125:272-279.
36. Xue Y., Zhao Z.Q., Chen F., Zhang L., Li G.D., Ma K.W., Bai X.F., Zuo Y.J. Polymorphisms in the promoter of the CD14 gene and their associations with susceptibility to pulmonary tuberculosis. Tissue Antigens 2012, 80:437-443.
37. Yim J.J., Selvaraj P. Genetic susceptibility in tuberculosis. Respirology 2010, 15:241-256.
38. Zaman K. Tuberculosis: a global health problem. J. Health Popul. Nutr. 2010, 28:111-113.
39. Zeng T., Guo F.F., Zhang C.L., Song F.Y., Zhao X.L., Xie K.Q. Roles of cytochrome P4502E1 gene polymorphisms and the risks of alcoholic liver disease: a meta-analysis. PloS One 2013, 8:e54188.
40. Zhang J., Chen Y., Nie X.B., Wu W.H., Zhang H., Zhang M., He X.M., Lu J.X. Interleukin-10 polymorphisms and tuberculosis susceptibility: a meta-analysis. Int. J. Tuberc. Lung Dis. 2011, 15:594-601.
41. Zhang Y., Zhang J., Zeng L., Huang H., Yang M., Fu X., Tian C., Xiang Z., Huang J., Fan H. The -2518A/G polymorphism in the MCP-1 gene and tuberculosis risk: a meta-analysis. PLoS One 2012, 7:e38918.
42. Zhao M.Y., Xue Y., Zhao Z.Q., Li F.J., Fan D.P., Wei L.L., Sun X.J., Zhang X., Wang X.C., Zhang Y.X., Li J.C. Association of CD14 G(-1145)A and C(-159)T polymorphisms with reduced risk for tuberculosis in a Chinese Han population. Genet. Mol. Res. 2012, 11:3425-3431.